Jennifer Kayden Lee, EVP, Head of North America at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 4,070 shares at $57.22 ($233K) on 2025-02-19, disclosed to the SEC on 2025-02-19.
Scheduled sale ($233k) by EVP, Head of North America under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.22 | 2,035 | $116K | 50.0% |
| 2 | $57.22 | 2,035 | $116K | 50.0% |
| Total | $57.22 avg | 4,070 | $233K | 100% |
| Filing → |
| RYTM | SELL | 2025-02-11 | $611K | — | Filing → |
| RYTM | SELL | 2025-02-07 | $359K | — | Filing → |
| RYTM | SELL | 2025-02-04 | $172K | — | Filing → |